NCM
RNLX

Nantahala Capital Management’s Renalytix plc American Depositary Shares RNLX Stock Holding History

Nantahala Capital Management’s Portfolio RNLX Stock Details RNLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-117,644
Closed -$24.6K – 153
2024
Q3 		$24.6K Hold
117,644
– – ﹤0.01% 136
2024
Q2 		$27.2K Hold
117,644
– – ﹤0.01% 129
2024
Q1 		$101K Buy
+117,644
New +$80.6K 0.01% 118

Other funds holding RNLX

XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return
IIC
Ironwood Investment Counsel Scottsdale, Arizona $762M AUM 23.02% 1-Year Est. Return

Nantahala Capital Management's RNLX Position: Q4 2024 in Review

Nantahala Capital Management sold out of Renalytix plc American Depositary Shares (RNLX) in Q4 2024, closing a stake of 117,644 shares — an estimated $24.6K sold.

Nantahala Capital Management first reported a position in RNLX in Q1 2024 and held it in 3 quarters. The position peaked at $101K in Q1 2024. 3 funds tracked by Wall St. Rank hold RNLX as of Q4 2024.

  • Nantahala Capital Management reported no remaining Renalytix plc American Depositary Shares position as of Q4 2024 after selling out during the quarter.
  • Nantahala Capital Management sold 117,644 Renalytix plc American Depositary Shares shares in Q4 2024, an estimated $24.6K.
  • Nantahala Capital Management first reported a position in Renalytix plc American Depositary Shares in Q1 2024 and held it in 3 quarters.
  • Nantahala Capital Management's Renalytix plc American Depositary Shares position peaked at $101K in Q1 2024.
  • 3 funds tracked by Wall St. Rank held Renalytix plc American Depositary Shares as of Q4 2024.

Based on Nantahala Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.